Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypertension and the eye: changing perspectives.

S Chatterjee1, S Chattopadhyay, M Hope-Ross

  • 1The Birmingham and Midland Eye Centre, City Hospital, Birmingham, UK.

Journal of Human Hypertension
|November 7, 2002
PubMed
Summary

Systemic hypertension causes target-organ damage, including retinopathy, increasing cardiovascular risk. Recognizing hypertensive retinopathy aids in risk stratification for hypertensive patients.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Efficacy and timing of adjunctive therapy in the anti-VEGF treatment regimen for macular oedema in retinal vein occlusion: 12-month real-world result.

Eye (London, England)·2017
Same author

Report of 12-months efficacy and safety of intravitreal fluocinolone acetonide implant for the treatment of chronic diabetic macular oedema: a real-world result in the United Kingdom.

Eye (London, England)·2017
Same author

Associations of retinal artery occlusion and retinal vein occlusion to mortality, stroke, and myocardial infarction: a systematic review.

Eye (London, England)·2016
Same author

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes.

Eye (London, England)·2016
Same author

Intravitreal fluocinolone acetonide (Iluvien) for treatment of refractory diabetic macular oedema in vitrectomised eyes.

Eye (London, England)·2016
Same author

Peri-operative management of ophthalmic patients taking antithrombotic therapy.

International journal of clinical practice·2011

Area of Science:

  • Ophthalmology
  • Cardiology
  • Nephrology

Background:

  • Systemic hypertension is a prevalent condition linked to substantial morbidity and mortality.
  • Hypertension contributes to cardiovascular risk through target-organ damage, affecting the eyes, heart, brain, kidneys, and peripheral vasculature.
  • Identifying hypertensive retinopathy is crucial for assessing cardiovascular risk in individuals with hypertension.

Purpose of the Study:

  • To reevaluate current understanding of hypertensive retinopathy.
  • To review evolving perspectives on the pathophysiology of fundal lesions in hypertension.
  • To examine updated classifications and the prognostic significance of these lesions.

Main Methods:

  • Literature review of recent studies on hypertensive retinopathy.

Related Experiment Videos

  • Analysis of current research on the pathophysiology and classification of hypertensive fundal changes.
  • Synthesis of data regarding the prognostic implications of retinopathy in hypertensive individuals.

    • Main Results:

    • Hypertensive retinopathy reflects systemic vascular damage and is a key indicator of cardiovascular risk.
    • Classification systems for hypertensive retinopathy continue to evolve with new imaging and diagnostic technologies.
    • The presence and severity of retinopathy correlate with the risk of adverse cardiovascular and cerebrovascular events.

    Conclusions:

    • Hypertensive retinopathy remains a critical sign for cardiovascular risk stratification.
    • Ongoing research refines our understanding of its pathophysiology and clinical significance.
    • Clinicians should be vigilant in recognizing and interpreting fundal lesions in hypertensive patients for comprehensive risk assessment.